The Effect of Malaria-Induced Alteration of Metabolism on Piperaquine Disposition in Plasmodium yoelii-Infected mice, as Well as Predicted in Malaria Patients.

Malaria PBPK modeling clearance drug metabolizing enzymes piperaquine

Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 07 12 2023
revised: 08 05 2024
accepted: 11 05 2024
medline: 19 5 2024
pubmed: 19 5 2024
entrez: 18 5 2024
Statut: aheadofprint

Résumé

Malaria-induced alteration of physiological parameters and pharmacokinetic properties of antimalarial drugs may be clinically relevant. Whether and how malaria alters the disposition of piperaquine (PQ) was investigated in this study. The effect of malaria on drug metabolism-related enzymes and PQ pharmacokinetic profiles was studied in Plasmodium yoelii-infected mice in vitro/in vivo. Whether the malaria effect was clinically relevant for PQ was evaluated using a validated physiologically-based pharmacokinetic (PBPK) model with malaria-specific scalars obtained in mice. The infection led to a higher blood-to-plasma partitioning (R The malaria-induced alteration of drug metabolism was substrate-dependent, and its impact on the disposition of PQ and maybe other long-acting aminoquinoline antimalarials was not expected to be clinically relevant.

Sections du résumé

BACKGROUND BACKGROUND
Malaria-induced alteration of physiological parameters and pharmacokinetic properties of antimalarial drugs may be clinically relevant. Whether and how malaria alters the disposition of piperaquine (PQ) was investigated in this study.
METHODS METHODS
The effect of malaria on drug metabolism-related enzymes and PQ pharmacokinetic profiles was studied in Plasmodium yoelii-infected mice in vitro/in vivo. Whether the malaria effect was clinically relevant for PQ was evaluated using a validated physiologically-based pharmacokinetic (PBPK) model with malaria-specific scalars obtained in mice.
RESULTS RESULTS
The infection led to a higher blood-to-plasma partitioning (R
CONCLUSIONS CONCLUSIONS
The malaria-induced alteration of drug metabolism was substrate-dependent, and its impact on the disposition of PQ and maybe other long-acting aminoquinoline antimalarials was not expected to be clinically relevant.

Identifiants

pubmed: 38761871
pii: S0924-8579(24)00127-4
doi: 10.1016/j.ijantimicag.2024.107209
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107209

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest None to declare.

Auteurs

Yuewu Xie (Y)

School of Pharmaceutical Sciences, Shandong University, 250012, Jinan, China.

Yifan Zhang (Y)

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201210, Shanghai, China.

Feifei Lin (F)

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201210, Shanghai, China.

Xiaoyue Chen (X)

School of Pharmaceutical Sciences, Shandong University, 250012, Jinan, China.

Jie Xing (J)

School of Pharmaceutical Sciences, Shandong University, 250012, Jinan, China. Electronic address: xingjie@sdu.edu.cn.

Classifications MeSH